These findings suggest that apigenin can reduce uPAR expression via modulating the (ERK1/2, JNK)/Activator protein 1 and (ERK1/2, JNK)/NF-κB signalling pathways in human bladder cancer cells [75]. This evidence concerns the gene PLAUR and urinary bladder cancer.